2012
DOI: 10.1001/2012.jama.10647
|View full text |Cite
|
Sign up to set email alerts
|

Changes in Direct-to-Consumer Pharmaceutical Advertising Following Shifts From Prescription-Only to Over-the-Counter Status

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
6
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 3 publications
0
6
0
Order By: Relevance
“…New standards for health care advertising should be designed to promote informed health care decisions, in keeping with the responsibility of health care institutions to protect patient wellbeing. As such, these standards might adapt aspects of FDA regulations for pharmaceutical advertisements, such as the guidelines for risk disclosure designed not merely to avoid deception, but to provide consumers with a "fair balance" of information about benefits and harms (Greene et al 2012; U.S. Department of Health and Human Services, Food and Drug Administration 2009). While we do not make any claims about the effectiveness of FDA guidelines, they are an additional layer of oversight that have helped to focus attention on the potential risks of advertising prescription drugs directly to patients.…”
Section: Resultsmentioning
confidence: 99%
“…New standards for health care advertising should be designed to promote informed health care decisions, in keeping with the responsibility of health care institutions to protect patient wellbeing. As such, these standards might adapt aspects of FDA regulations for pharmaceutical advertisements, such as the guidelines for risk disclosure designed not merely to avoid deception, but to provide consumers with a "fair balance" of information about benefits and harms (Greene et al 2012; U.S. Department of Health and Human Services, Food and Drug Administration 2009). While we do not make any claims about the effectiveness of FDA guidelines, they are an additional layer of oversight that have helped to focus attention on the potential risks of advertising prescription drugs directly to patients.…”
Section: Resultsmentioning
confidence: 99%
“…Once medications are nonprescription they will be monitored by the Federal Trade Commission and will be responsible for representing both benefits and risks of medication. [ 5 ]…”
Section: Drug Requirements For Switchmentioning
confidence: 99%
“…5 The function of this regulation is to make sure that the information delivered to the society is true and beneficial.5 However, many pharmaceutical companies produce advertisements only to increase their profit rather than to give adequate information about their products, as not all information is written in the advertisement. 6 Thus, these misleading advertisements consist of inadequate information regarding their products.…”
Section: Introductionmentioning
confidence: 99%